Involvement of dynorphin and kappa opioid receptor in yohimbine-induced reinstatement of heroin seeking in rats

Synapse

Volumn 67, Issue 6, 2013, Pages 358-361

  Zhou, Yan ^a   Leri, Francesco ^b   Grella, Stephanie L ^b   Aldrich, Jane V ^c   Kreek, Mary Jeanne ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY OF GUELPH   (Canada)

^c UNIVERSITY OF KANSAS   (United States)

Author keywords

Central nucleus of the amygdala; Dynorphin; Heroin self administration; Kappa opioid receptor; Nucleus accumbens shell; Yohimbine induced reinstatement

Indexed keywords

DIAMORPHINE; DYNORPHIN; KAPPA OPIATE RECEPTOR; YOHIMBINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG SEEKING BEHAVIOR; NEUROCHEMISTRY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REINFORCEMENT; STRESS;

ADRENERGIC ALPHA-2 RECEPTOR ANTAGONISTS; ANIMALS; BRAIN; DRUG-SEEKING BEHAVIOR; DYNORPHINS; HEROIN; LEARNING; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; YOHIMBINE;

EID: 84876452130     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21638     Document Type: Article

References (24)

1. Aldrich JV, McLaughlin JP. 2009. Peptide kappa opioid receptor ligands: Potential for drug development. AAPS J 11:312-322.
2. Aldrich JV, Patkar KA, McLaughlin JP. 2009. Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action. Proc Natl Acad Sci USA 106:18396-18401.
3. Beardsley PM, Howard JL, Shelton KL, Carroll FI. 2005. Differential effects of the novel kappa opioid receptor antagonist JDTic on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats. Psychopharmacology 183:118-126.
4. Cippitelli A, Damadzic R, Hansson AC, Singley E, Sommer WH, Eskay R, Thorsell A, Heilig M. 2010. Neuropeptide Y (NPY) suppresses yohimbine-induced reinstatement of alcohol seeking. Psychopharmacology 208:417-426.
5. Jackson KJ, Carroll FI, Negus SS, Damaj MI. 2010. Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse. Psychopharmacology 210:285-294.
6. Knoll AT, Carlezon WA Jr. 2010. Dynorphin, stress, and depression. Brain Res 1314:56-73.
7. Koob GF, Kreek MJ. 2007. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 164:1149-1159.
8. Leri F, Flores J, Rodaros D, Stewart J. 2002. Blockade of stress-induced but not cocaine-induced reinstatement by infusion of noradrenergic antagonists into the bed nucleus of the stria terminalis or the central nucleus of the amygdala. J Neurosci 22:5713-5718.
9. Maiya R, Zhou Y, Norris E, Kreek MJ, Strickland S. 2009. Tissue plasminogen activator modulates cellular and behavioral response to cocaine. Proc Natl Acad Sci USA 106:1983-1988.
10. McLaughlin JP, Land BB, Li S, Pintar JE, Chavkin C. 2006. Prior activation of kappa opioid receptors by U50, 488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning. Neuropsychopharmacology 31:787-794.
11. Newton SS, Thome J, Wallace T, Shirayama Y, Schlesinger L, Sakai N, Chen J, Neve R, Nestler EJ, Duman RS. 2002. Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect. J Neurosci 22:10883-10890.
12. Rosen MI, Kosten TR, Kreek MJ. 1999. The effects of naltrexone maintenance on the response to yohimbine in healthy volunteers. Biol Psychiatry 45:1636-1645.
13. See RE, Waters RP. 2010. Pharmacologically-induced stress: A cross-species probe for translational research in drug addiction and relapse. Am J Transl Res 3:81-89.
14. Shaham Y, Shalev U, Lu L, de Wit H, Stewart J. 2003. The reinstatement model of drug relapse: History, methodology and major findings. Psychopharmacology 168:3-20.
15. Shippenberg TS, Zapata A, Chefer VI. 2007. Dynorphin and the pathophysiology of drug addiction. Pharmacol Ther 116:306-321.
16. Sinha R, Garcia M, Paliwal P, Kreek MJ, Rounsaville BJ. 2006. Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch Gen Psychiatry 63:324-331.
17. Sinha R, Shaham Y, Heilig M. 2011. Translational and reverse translational research on the role of stress in drug craving and relapse. Psychopharmacology 218:69-82.
18. Spanagel R, Herz A, Shippenberg TS. 1992. Opposing tonically active endogenous opioid systems modulate mesolimbic dopaminergic pathway. Proc Natl Acad Sci USA 89:2046-2050.
19. Stine S, Southwick S, Petrakis I, Kosten T, Charney D, Krystal J. 2002. Yohimbine-induced withdrawal and anxiety symptoms in opioid dependent patients. Biol Psychiatry 51:642-651.
20. Todtenkopf MS, Marcus JF, Portoghese PS, Carlezon WA Jr. 2004. Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats. Psychopharmacology 172:463-270.
21. Walker BM, Koob GF. 2008. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. Neuropsychopharmacology 33:643-652.
22. Wee S, Orio L, Ghirmai S, Cashman JR, Koob GF. 2009. Inhibition of kappa opioid receptors attenuated increased cocaine intake in rats with extended access to cocaine. Psychopharmacology 205:565-275.
23. Zhang Y, Butelman ER, Schlussman SD, Ho A, Kreek MJ. 2004. Effect of the endogenous kappa opioid opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal dopamine levels and cocaine induced place preference in C57BL/6J mice. Psychopharmacology 172:422-429.
24. Zhou Y, Leri F, Cummins E, Hoeschele M, Kreek MJ. 2008. Involvement of arginine vasopressin and V1b receptor in heroin withdrawal and heroin seeking precipitated by stress and by heroin. Neuropsychopharmacology 33:226-236.